Position in NVAX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$892,629
+$36,562 QoQ
Shares Held
94,759
-9.9% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#66
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $50,552,262 across 50 Biotechnology names. NVAX ranks #15 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,129 | $13,798,316 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
146,259 | $5,705,563 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
15,400 | $2,884,112 | |
| 4 | TYRA |
Tyra Biosciences, Inc.
|
83,783 | $2,676,029 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,250 | $2,111,102 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
99,771 | $1,860,729 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
75,714 | $1,823,193 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
107,453 | $1,818,104 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $892,629 | 94,759 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $856,067 | 105,168 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $240,649 | 35,811 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $641,085 | 73,943 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $431,877 | 68,552 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $325,230 | 50,738 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $350,326 | 43,573 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $151,736 | 12,014 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $147,413 | 11,644 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $57,928 | 12,119 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $70,507 | 14,689 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $118,497 | 16,367 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $142,039 | 19,117 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $164,012 | 23,667 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $249,464 | 24,267 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $618,581 | 33,988 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,810,752 | 54,652 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $4,389,687 | 59,602 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,316,540 | 44,150 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $6,209,556 | 29,953 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,074,500 | 5,061 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,038,362 | 5,727 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $445,705 | 3,997 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $418,231 | 3,860 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $659,881 | 7,917 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $382,725 | 28,183 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||